Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer / Regan, M.m., Price, K.n., Giobbie-Hurder, A., Thürlimann, B., Gelber, R.d., International Breast Cancer Study Group and BIG 1-98 Collaborative Group (Thürlimann, B., Aebi, S., Blacher, L., Coates, A.s., Cufer, T., Forbes, J., Gelber, R.d., Giobbie-Hurder, A., Goldhirsch, A., Hiltbrunner, A., Holmberg, S.b., Maibach, R., Martoni, A., Mauriac, L., Macgrogan, G., et al.. - In: BREAST CANCER RESEARCH. - ISSN 1465-5411. - 13:(2011).

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Mastropasqua M;
2011-01-01

File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/188313
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 69
  • ???jsp.display-item.citation.isi??? 59
social impact